Hypertrophic Cardiomyopathy (HCM)
Vaccines: 2023 Year in Review
Eyecare
Urothelial Carcinoma
Women's Health
Hemophilia
Heart Failure
Vaccines
Neonatal Care
NSCLC
Type II Inflammation
Substance Use Disorder
Gene Therapy
Lung Cancer
Spinal Muscular Atrophy
HIV
Post-Acute Care
Liver Disease
Pulmonary Arterial Hypertension
Biologics
Asthma
Atrial Fibrillation
Type I Diabetes
RSV
COVID-19
Cardiovascular Diseases
Breast Cancer
Prescription Digital Therapeutics
Reproductive Health
The Improving Patient Access Podcast
Blood Cancer
Ulcerative Colitis
Respiratory Conditions
Multiple Sclerosis
Digital Health
Population Health
Sleep Disorders
Biosimilars
Plaque Psoriasis
Leukemia and Lymphoma
Oncology
Pediatrics
Urology
Obstetrics-Gynecology & Women's Health
Opioids
Solid Tumors
Autoimmune Diseases
Dermatology
Diabetes
Mental Health

How Diagnostic Robotics Unlocks the Full Potential Value of Care Management

November 2, 2022

Article

Sponsored Content

Artificial intelligence (AI) is becoming a critical resource for health plans to reduce cost of care and improve patient outcomes. By proactively identifying members whose risk for adverse health events is preventable and who are likely to engage, AI models can help these plans understand where care management outreach has the most impact on lives, member satisfaction, and ROI.

Learn how a Diagnostic Robotics AI-powered solution helped Blue Cross Blue Shield of Rhode Island target members within its congestive heart failure (CHF) and spinal care (MSK) programs to identify avoidable surgeries and hospitalizations and drive significant cost savings.

Complete the form below to learn more.